4MO Prognostic implication of 21-gene expression assay in luminal B type hormone receptor-positive breast cancer patients younger than 40 years

J. Hyung, S. Lee, J. Kim, H.J. Kim, B. Ko,B-H. Son, J. Lee, H.J. Lee, G. Gong, H. Lee,H. Jeong,J-H. Jeong, J.E. Kim,J-H. Ahn,K.H. Jung,S-B. Kim

Annals of Oncology（2022）

引用 0|浏览1

暂无评分

摘要

Recurrence score (RS) based on 21-gene expression assay is widely used to evaluate prognosis and potential benefits of adjuvant chemotherapy (AC) for hormone-receptor positive (HR+) breast cancer (BC) patients (pts). In this study, we investigated clinical significance of RS in premenopausal HR+ BC pts.

查看译文

关键词

breast cancer,breast cancer patients,receptor-positive

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要